NL
NL · NL · NL-c203fd1bfa37
AGAMREE 40 mg/ml suspensie voor oraal gebruik
ATC H02AB18
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerSanthera Pharmaceuticals (Deutschland) GmbH
CountryNL (NL)
ATC codeH02AB18
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/23/1776
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Suspensie voor oraal gebruik",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/agamree-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Vamorolone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130593",
"excipients": [
"CITROENZUUR 1-WATER (E 330)",
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"GLYCEROL (E 422)",
"NATRIUMBENZOAAT (E 211)",
"SINAASAPPELSMAAKSTOF",
"SUCRALOSE (E 955)",
"WATER, GEZUIVERD",
"XANTHAANGOM (E 415)",
"ZOUTZUUR (E 507)"
],
"substances": [
"VAMOROLON"
],
"leaflet_url": null,
"authorised_at": "2023/12/14",
"procedure_number": "EMEA/H/C/005679",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/23/1776",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code H02AB18.
- NOAgamreeSanthera Pharmaceuticals (Deutschland) GmbH
- PLAgamreeSanthera Pharmaceuticals (Deutschland) GmbH
- ISAgamreeSanthera Pharmaceuticals (Deutschland) GmbH
- FIAGAMREESanthera Pharmaceuticals (Deutschland) GmbH
- CZAGAMREESanthera Pharmaceuticals (Deutschland) GmbH, Lörrach
- DKAGAMREESanthera Pharmaceuticals (Deutschland) GmbH
- BEAgamree 40 mg/mlSanthera Pharmaceuticals (Deutschland)
- IEAGAMREE 40 mg/ml oral suspensionSanthera Pharmaceuticals (Deutschland) GmbH
Access this data programmatically
Query AGAMREE 40 mg/ml suspensie voor oraal gebruik and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.